Hypotensive shock as a complication of infracyanine green injection.
Bonte
C A
CA
Department of Ophthalmology, University Hospitals, Leuven, Belgium.
Ceuppens
J
J
Leys
A M
AM
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects*; D004396:Coloring Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D005260:Female; D005451:Fluorescein Angiography / Q000009:adverse effects; D005654:Fundus Oculi; D005938:Glucocorticoids / Q000627:therapeutic use; D018475:Head-Down Tilt; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D007208:Indocyanine Green / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008268:Macular Degeneration / Q000150:complications / Q000175:diagnosis; D012163:Retinal Detachment / Q000175:diagnosis / Q000209:etiology; D012769:Shock / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D004396:Coloring Agents; D005938:Glucocorticoids; D006633:Histamine Antagonists; C116320:Infracyanine green; D014662:Vasoconstrictor Agents; D007208:Indocyanine Green